Immunosuppression in cardiac transplantation

New England Journal of Medicine

Volumn 352, Issue 26, 2005, Pages 2749-2750

  Hosenpud, Jeffrey D ^a  

^a St Luke's Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DACLIZUMAB; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; IMMUNOGLOBULIN G;

CLINICAL TRIAL; DRUG FATALITY; EDITORIAL; GRAFT DYSFUNCTION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; KIDNEY INJURY; MORTALITY; PATIENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, MONOCLONAL; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 21244474870     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe058087     Document Type: Editorial

References (6)

1. Hershberger RE, Starling RC, Eisen HJ, et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 2005;352: 2705-13.
2. Kobashigawa J, Miller L, Renlund D, et al. A randomized activecontrolled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998;66:507-15.
3. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 2003;349:847-58.
4. Kobashigawa JW, Miller LW, Felker GM, et al. 12 Month report of a 3 arm multicenter comparison of tacrolimus (TAC), MMF or TAC/Sirolimus (SRL) and steroids vs cyclosporine microemulsion (CYA), MMF and steroids in de novo cardiac transplant recipients. J Heart Lung Transplant 2005;24:S61. abstract.
5. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: eighteenth official report - 2001. J Heart Lung Transplant 2001;20:805-15.
6. Kirklin JK, Naftel DC, Bourge RC, et al. Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. J Thorac Cardiovasc Surg 2003;125:881-90.